研究单位：[1]Shanghai Pharmaceuticals Holding Co., Ltd[2]The First Affiliated Hospital，Sun Yat-sen University,Guangzhou,Guangdong,China,510080[3]The Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou,Guangdong,China,510655[4]Huizhou First Hospital,Huizhou,Guangdong,China[5]Nanfang Hospital, Southern Medical University,Guangzhou,Guanmgdong,China[6]Affiliated Hospital of Hebei University,Baoding,Hebei,China[7]The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei,China[8]The First Affiliated Hospital of Henan University,Kai Feng,Henan,China[9]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China[10]Union Hospital Tongji Medical College Huazhong Universitu of Science and Technology,Wuhan,Hubei,China,430000[11]Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,China,430030[12]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430060[13]The First Hospital of Hunan University of Chinese Medicine,Changsha,Hunan,China[14]The First Affiliated Hospital of University of South China,Hengyang,Hunan,China,675299[15]The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China,221000[16]Shengjing Hospital affiliated to China Medical University,Shenyang,Liaoning,China,110136[17]General Hospital of Ningxia Medical University,Yinchuan,Ningxia,China,750004[18]Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan,Shandong,China[19]Xi''an Central Hospital,Xi''an,Shanxi,China[20]Suining Central Hospital,Suining,Sichuan,China[21]Beijing Chao-Yang Hospital,Capital Medical University,Beijing,China,100020[22]Peking University Third Hospital,Beijing,China[23]Chifeng Municipal Hospital,Chifeng,China[24]The First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou,China,310003[25]Shanghai Jiaotong University School of Medicine, Renji Hospital,Shanghai,China,200001[26]Tianjin Medical University General Hospital[27],Tianjin,China,300052
研究目的：
To preliminarily evaluate the clinical efficacy of the renin inhibitor SPH3127 Tablets in patients with mild to moderate ulcerative colitis with placebo as a control and determine the recommended dose.
